Dr. Josep Rodes-Cabau
Claim this profileIUCPQ
Affiliated Hospitals
IUCPQ
Institut Universitaire De Cardiologie Et De Pneumologie De Québec (IUCPQ)
Clinical Trials Josep Rodes-Cabau is currently running
Cephea Valve System
for Mitral Regurgitation
This trial is testing a new device called the Cephea Mitral Valve System that can fix or replace a damaged heart valve using a thin tube. It aims to help patients with mitral valve disease who need a less invasive treatment than open-heart surgery. The Cephea Mitral Valve System is a new technology developed by Cephea Valve Technologies, aiming to treat severe mitral regurgitation through a less invasive approach.
Recruiting
1 award
N/A
SAPIEN 3 Ultra RESILIA Valve
for Aortic Valve Stenosis
The issue of valve durability has become one of the most important aspects in the TAVR field in recent years since transcatheter aortic valve replacement has been progressively applied to younger patients with a low co-morbidity burden. The SAPIEN 3 Ultra RESILIA valve represents the last generation of the SAPIEN valve system and includes several important iterations (newer leaflet calcium-blocking technology targeting calcium-attracting free aldehydes, dry tissue storage, newer skirt textile design) that should translate into a favorable impact on valve durability at mid- to long- term follow-up
Recruiting
1 award
N/A
6 criteria
More about Josep Rodes-Cabau
Clinical Trial Related
7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Josep Rodes-Cabau has experience with
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
- Transcatheter Aortic Valve Replacement
- Antiplatelet Treatment Discontinuation
- Cardiostat
- Edwards
Breakdown of trials Josep Rodes-Cabau has run
Aortic Valve Stenosis
Aortic Stenosis
Transcatheter Aortic Valve Replacement
Aortic Regurgitation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Josep Rodes-Cabau specialize in?
Josep Rodes-Cabau focuses on Aortic Valve Stenosis and Aortic Stenosis. In particular, much of their work with Aortic Valve Stenosis has involved treating patients, or patients who are undergoing treatment.
Is Josep Rodes-Cabau currently recruiting for clinical trials?
Yes, Josep Rodes-Cabau is currently recruiting for 4 clinical trials in Quebec City Quebec. If you're interested in participating, you should apply.
Are there any treatments that Josep Rodes-Cabau has studied deeply?
Yes, Josep Rodes-Cabau has studied treatments such as Evolut FX TAVR System, Medtronic Evolut PRO+ TAVR System, Transcatheter Aortic Valve Replacement.
What is the best way to schedule an appointment with Josep Rodes-Cabau?
Apply for one of the trials that Josep Rodes-Cabau is conducting.
What is the office address of Josep Rodes-Cabau?
The office of Josep Rodes-Cabau is located at: Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec G1V 4G5 Canada. This is the address for their practice at the Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.